Where could CERS trade next? Consensus target price: $4.
Get informed when a big investor buys or sells
+ Follow$2.72
1 analysts in the last 4 months
High: $4 | Low: $4
No recommendations in the last 4 months.
Cerus (CERS) currently reports a target price of $4. Use the charts on this page to explore Cerus's target price history and peer comparisons.
Analysts' average 12-month price target for Cerus is $4, about 47.1% upside from the current share price of $2.72. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $4, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cerus, and consider following CERS for alerts when major investors trade the stock.
Cerus is classified in the Healthcare sector. On target price, it currently shows $4. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CERS with unrelated industries.